FIELD: biotechnology.
SUBSTANCE: invention relates to the field of biotechnology, in particular to an antibody or its antigen-binding fragment that specifically binds to MELK (maternal embryonic leucine zipper kinase) protein or its partial peptide, a method for its production, as well as to a reagent containing it and a labeled body. Polynucleotide encoding the above-mentioned antibody or its fragment is also disclosed.
EFFECT: invention is effective for the detection of MELK protein in a sample, for the determination of the drug effect after the treatment using MELK inhibitor in a subject, as well as for the diagnostics of MELK-associated disease or predisposition to the development of the specified disease in a subject.
15 cl, 4 dwg, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| MONOCLONAL ANTIBODY AGAINST FZD10, ITS USE | 2017 |
|
RU2765431C2 |
| AIMED AT UPARAP ANTIBODY-DRUG CONJUGATES | 2017 |
|
RU2740311C2 |
| STABLE COMPOSITIONS OF ANTI-TIGIT ANTIBODIES, INDIVIDUALLY AND IN COMBINATION WITH ANTIBODIES AGAINST PROGRAMMED DEATH RECEPTOR 1 (PD-1), AND METHODS OF THEIR USE | 2018 |
|
RU2820576C2 |
| PROTEINS BINDING NKG2D, CD16 AND TUMOUR-ASSOCIATED ANTIGEN | 2018 |
|
RU2816716C2 |
| FUNCTION PROTEIN AND ITS USE | 2019 |
|
RU2800923C2 |
| ANTIBODIES AND ANALYSIS METHODS FOR FOLIC ACID 1 RECEPTOR DETECTION | 2014 |
|
RU2725825C2 |
| POLY-SPECIFIC BINDING PROTEINS TARGETED TO CAIX, ANO1, MESOTHELIN, TROP2, CEA, AND CLAUDINE-18.2 | 2018 |
|
RU2792671C2 |
| POLYSPECIFIC BINDING PROTEINS TARGETING NKG2D, CD16 AND TROP2 | 2018 |
|
RU2820629C2 |
| COMPOSITIONS AND METHODS FOR MODULATING THE TRANSMISSION OF A LAIR SIGNAL | 2017 |
|
RU2757394C2 |
| ANTIBODIES B7-H4 AND METHODS FOR THEIR APPLICATION | 2019 |
|
RU2809243C2 |
